| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1019260188 |
| P356 | DOI | 10.1245/S10434-010-1071-7 |
| P932 | PMC publication ID | 2924500 |
| P698 | PubMed publication ID | 20422460 |
| P5875 | ResearchGate publication ID | 43346649 |
| P2093 | author name string | Oscar J Hines | |
| Clifford Y Ko | |||
| Howard Reber | |||
| James Farrell | |||
| James S Tomlinson | |||
| Nabil Wasif | |||
| Zev Wainberg | |||
| P2860 | cites work | A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer | Q34546440 |
| Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database | Q34580491 | ||
| Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial | Q34602771 | ||
| Pancreatic resection in the elderly | Q35757205 | ||
| Strength of the evidence: adjuvant therapy for resected pancreatic cancer | Q37044642 | ||
| The staging of cancer: a retrospective and prospective appraisal | Q37156130 | ||
| Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival | Q37519827 | ||
| Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? | Q40573146 | ||
| Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas. | Q40766427 | ||
| Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience | Q43549764 | ||
| Survival after resection for ductal adenocarcinoma of the pancreas | Q43945731 | ||
| Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma | Q44116516 | ||
| Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients | Q46395249 | ||
| Accuracy of staging node-negative pancreas cancer: a potential quality measure | Q46500332 | ||
| Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database | Q46988284 | ||
| Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients | Q47206028 | ||
| Cytologic grade independently predicts survival of patients with pancreatic adenocarcinoma. | Q53655036 | ||
| Prognostic indicators for survival after resection of pancreatic adenocarcinoma. | Q53727950 | ||
| Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas | Q57846416 | ||
| A Proposal for a New and More Practical Grading Scheme for Pancreatic Ductal Adenocarcinoma | Q63865738 | ||
| Prognostic factors in the operative treatment of ductal pancreatic carcinoma | Q73422049 | ||
| Prognostic factors of long-term survival after resective procedures for pancreatic cancer | Q77553183 | ||
| 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience | Q79369906 | ||
| Outcomes in octogenarians undergoing high-risk cancer operation: a national study | Q79950181 | ||
| P433 | issue | 9 | |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | 2312-2320 | |
| P577 | publication date | 2010-04-27 | |
| P1433 | published in | Annals of Surgical Oncology | Q2853069 |
| P1476 | title | Impact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging? | |
| P478 | volume | 17 |
| Q89845634 | A Nomogram for Individual Prediction of Poor Prognosis After Radical Surgery in Patients with Primary Pancreatic Duct Adenocarcinoma |
| Q34941883 | A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma |
| Q35101113 | A mutated anti-CA19-9 scFv-Fc for positron emission tomography of human pancreatic cancer xenografts |
| Q35176131 | A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitor |
| Q87393266 | Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia |
| Q64280213 | Adjuvant chemotherapy followed by concurrent chemoradiation is associated with improved survival for resected stage I-II pancreatic cancer |
| Q38102914 | Advanced-stage pancreatic cancer: therapy options |
| Q39014939 | CARMA3 is upregulated in human pancreatic carcinoma, and its depletion inhibits tumor proliferation, migration, and invasion |
| Q37508923 | CT-perfusion measurements in pancreatic carcinoma with different kinetic models: Is there a chance for tumour grading based on functional parameters? |
| Q35629707 | Conditional survival in pancreatic cancer: better than expected |
| Q50918212 | DNA-Methyltransferase 1 Induces Dedifferentiation of Pancreatic Cancer Cells through Silencing of Krüppel-Like Factor 4 Expression. |
| Q91744515 | Development and multicenter validation of a CT-based radiomics signature for discriminating histological grades of pancreatic ductal adenocarcinoma |
| Q94552683 | Development and validation of a novel nomogram for predicting the prognosis of patients with resected pancreatic adenocarcinoma |
| Q39220786 | Diagnostic performance of endoscopic ultrasound for detection of pancreatic malignancy following an indeterminate multidetector CT scan: a systemic review and meta-analysis. |
| Q36925424 | Disparities in use of gynecologic oncologists for women with ovarian cancer in the United States |
| Q44369668 | Does long-term survival in patients with pancreatic cancer really exist? Results from the CONKO-001 study |
| Q87163763 | Effect of CD74 on the prognosis of patients with resectable pancreatic cancer |
| Q36161168 | Equipping the American Joint Committee on Cancer staging for resectable pancreatic ductal adenocarcinoma with tumor grade: a recursive partitioning analysis |
| Q37693530 | Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial. |
| Q34078502 | Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines |
| Q36850566 | Impact of Intratumoral Inflammation on Survival After Pancreatic Cancer Resection |
| Q33987127 | Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes |
| Q36869288 | Long-term survival in patients with pancreatic ductal adenocarcinoma |
| Q42661914 | Minimally invasive RAMPS in well-selected left-sided pancreatic cancer within Yonsei criteria: long-term (>median 3 years) oncologic outcomes |
| Q37998096 | Molecular pathology of pancreatic cancer: from bench-to-bedside translation |
| Q47192923 | Neoadjuvant therapy offers longer survival than upfront surgery for poorly differentiated and higher stage pancreatic cancer. |
| Q35609695 | Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system. |
| Q57136038 | Pancreatic cancer survival analysis defines a signature that predicts outcome |
| Q37499093 | Peripancreatic soft tissue involvement: independent outcome predictor in patients with resected pancreatic adenocarcinoma |
| Q41931582 | Predictive risk factors for peritoneal recurrence after pancreatic cancer resection and strategies for its prevention. |
| Q55253301 | Quantitative parameters of intravoxel incoherent motion diffusion weighted imaging (IVIM-DWI): potential application in predicting pathological grades of pancreatic ductal adenocarcinoma. |
| Q28075892 | Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas |
| Q42253007 | Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma |
| Q91976267 | Super-resolution recurrent convolutional neural networks for learning with multi-resolution whole slide images |
| Q93270269 | Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study |
| Q43439089 | The correlation of cortactin and fascin-1 expression with clinicopathological parameters in pancreatic and ampulla of Vater adenocarcinoma |
| Q36782384 | The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma |
| Q34093776 | Therapeutic options for the management of pancreatic cancer |
| Q38222441 | When to puncture, when not to puncture: Pancreatic masses. |
Search more.